RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190252

FDA DEVICE FACTS

MTS Gentamicin 0.016 - 256 µg/mL

Liofilchem s.r.l.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 22, 2019PRODUCT CODEJWY

Indications for use

Quantitative susceptibility to antimicrobial agents against Gram-negative organisms Quantitative susceptibility to antimicrobial agents against Gram-positive organisms Antibiotic Gentamicin code (CN) Vancomycin code (VA) Incubation 35 ± 2°C for 16 – 20 hours 35 ± 2°C for 24 hours

K. Standard/Guidance Document Referenced (if applicable):

• Guidance for Industry and FDA - Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems – August 28, 2009.

• CLSI M07-A10 “Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, Tenth Edition January 2015”.

• CLSI M100-Ed29 “Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Ninth Edition, January 2019”.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026